Based on the RECOVERY trial, glucocorticoids have become the mainstay of treatment for COVID-19, thus increasing the risk of opportunistic infections. We report a case of disseminated with documented meningoencephalitis in a patient with severe COVID-19 in the setting of prolonged glucocorticoid administration with poor outcome likely due to adrenal involvement.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734083 | PMC |
http://dx.doi.org/10.1016/j.idcr.2022.e01380 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!